NO20082816L - Farmasoytikum for anvendelse ved behandling av ureterolitiasis - Google Patents

Farmasoytikum for anvendelse ved behandling av ureterolitiasis

Info

Publication number: NO20082816L
Authority: NO; Norway
Prior art keywords: cyano; carbamoyl; substituent; lower alkyl; aryl
Prior art date: 2005-11-24

Application number

NO20082816A

Other languages

English (en)

Norwegian (no)

Inventor

Mamoru Kobayashi

Yoshitaka Tomiyama

Kumi Kobayashi

Original Assignee

Kissei Pharmaceutical

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-11-24

Filing date

2008-06-24

Publication date

2008-08-13

2008-06-24 Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical

2008-08-13 Publication of NO20082816L publication Critical patent/NO20082816L/no

Links

201000011086 ureterolithiasis Diseases 0.000 title abstract 2
125000000217 alkyl group Chemical group 0.000 abstract 3
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 3
125000004093 cyano group Chemical class *C#N 0.000 abstract 3
125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 2
239000008194 pharmaceutical composition Substances 0.000 abstract 2
239000004575 stone Substances 0.000 abstract 2
125000001424 substituent group Chemical group 0.000 abstract 2
239000004480 active ingredient Substances 0.000 abstract 1
125000003545 alkoxy group Chemical group 0.000 abstract 1
125000003118 aryl group Chemical group 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
125000003387 indolinyl group Chemical class N1(CCC2=CC=CC=C12)* 0.000 abstract 1
125000005400 pyridylcarbonyl group Chemical group N1=C(C=CC=C1)C(=O)* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229920006395 saturated elastomer Polymers 0.000 abstract 1
-1 substituent halogen Chemical class 0.000 abstract 1
210000000626 ureter Anatomy 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)

NO20082816A 2005-11-24 2008-06-24 Farmasoytikum for anvendelse ved behandling av ureterolitiasis NO20082816L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2005339188		2005-11-24
PCT/JP2006/323280 WO2007060974A1 (ja)	2005-11-24	2006-11-22	尿管結石症の治療用医薬

Publications (1)

Publication Number	Publication Date
NO20082816L true NO20082816L (no)	2008-08-13

Family

ID=38067199

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20082816A NO20082816L (no)	2005-11-24	2008-06-24	Farmasoytikum for anvendelse ved behandling av ureterolitiasis

Country Status (12)

Country	Link
US (2)	US20090163571A1 (ko)
EP (1)	EP1956001A4 (ko)
JP (1)	JP4865724B2 (ko)
KR (1)	KR101232425B1 (ko)
CN (1)	CN101336230B (ko)
BR (1)	BRPI0618996A2 (ko)
CA (1)	CA2628476C (ko)
EA (1)	EA016008B1 (ko)
NO (1)	NO20082816L (ko)
TW (1)	TW200803843A (ko)
UA (1)	UA92765C2 (ko)
WO (1)	WO2007060974A1 (ko)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE178210T1 (de) *	1992-09-14	1999-04-15	Forssmann Wolf Georg Prof Dr	Neue verwendung von inhibitoren der phosphodiesterase iv
DE69319551T2 (de) *	1992-12-02	1998-10-29	Kissei Pharmaceutical	Indolin Verbindungen zur Behandlung von Dysurien
JP4324266B2 (ja) *	1999-02-26	2009-09-02	キッセイ薬品工業株式会社	α１Ａアドレナリン受容体の変異体、当該変異体を用いた測定方法及び前立腺肥大に伴う排尿困難症治療剤
ATE295362T1 (de) *	2001-01-02	2005-05-15	Hoffmann La Roche	Chinazolone derivate als alfa 1a/b adrenozeptor antagonisten
JP2001288115A (ja) *	2001-02-07	2001-10-16	Yamanouchi Pharmaceut Co Ltd	下部尿路症治療剤
US20040072551A1 (en) *	2002-10-10	2004-04-15	Sanford John Richard	Communication device with front-end integration

2006
- 2006-11-22 UA UAA200808421A patent/UA92765C2/ru unknown
- 2006-11-22 CN CN2006800517242A patent/CN101336230B/zh not_active Expired - Fee Related
- 2006-11-22 US US12/093,230 patent/US20090163571A1/en not_active Abandoned
- 2006-11-22 CA CA2628476A patent/CA2628476C/en not_active Expired - Fee Related
- 2006-11-22 WO PCT/JP2006/323280 patent/WO2007060974A1/ja not_active Ceased
- 2006-11-22 JP JP2007546458A patent/JP4865724B2/ja not_active Expired - Fee Related
- 2006-11-22 KR KR1020087015259A patent/KR101232425B1/ko not_active Expired - Fee Related
- 2006-11-22 BR BRPI0618996-2A patent/BRPI0618996A2/pt not_active IP Right Cessation
- 2006-11-22 EP EP06823507A patent/EP1956001A4/en not_active Withdrawn
- 2006-11-22 EA EA200801420A patent/EA016008B1/ru not_active IP Right Cessation
- 2006-11-23 TW TW095143355A patent/TW200803843A/zh not_active IP Right Cessation
2008
- 2008-06-24 NO NO20082816A patent/NO20082816L/no not_active Application Discontinuation
2011
- 2011-04-13 US US13/086,040 patent/US20110230538A1/en not_active Abandoned

Also Published As

Publication number	Publication date
TWI379680B (ko)	2012-12-21
US20090163571A1 (en)	2009-06-25
BRPI0618996A2 (pt)	2011-09-20
KR20080071603A (ko)	2008-08-04
EA016008B1 (ru)	2012-01-30
JP4865724B2 (ja)	2012-02-01
TW200803843A (en)	2008-01-16
WO2007060974A1 (ja)	2007-05-31
KR101232425B1 (ko)	2013-02-12
EA200801420A1 (ru)	2009-02-27
HK1125634A1 (en)	2009-08-14
EP1956001A1 (en)	2008-08-13
EP1956001A4 (en)	2012-12-26
CA2628476A1 (en)	2007-05-31
JPWO2007060974A1 (ja)	2009-05-07
CN101336230B (zh)	2011-11-23
US20110230538A1 (en)	2011-09-22
UA92765C2 (ru)	2010-12-10
CN101336230A (zh)	2008-12-31
CA2628476C (en)	2013-10-15

Similar Documents

Publication	Publication Date	Title
NO20071521L (no)	2007-06-11	Nye fenylaminopyrimidin derivater som hemmere av BCR-ABL kinase
NO20090202L (no)	2009-03-23	Prolylhydroksylaseinhibitorer
NO20082346L (no)	2008-08-04	Hydrazonderivater og anvendelser derav
NO20076195L (no)	2008-02-27	Nye 2-azetidinonderivater for behandling av hyperlipidemiske sykdommer
NO20076196L (no)	2008-02-29	Nye 2-azetidinonderivater som kolesterolabsorpsjonsinhibitorer for behandling av hyperlipidemiske tilstander
NO20076479L (no)	2008-01-29	Nye oksadiazolderivater og anvendelse derav som positive allosteriske metabotropiske modulatorer av glutamatreseptorer
NO20076478L (no)	2008-01-28	Substituerte oksadiazolderivater som positive allosteriske modulatorer av metabotrope glutamatreseptorer
NO20056192L (no)	2005-12-27	Kapaseinhibitorer og anvendelse derav
NO20073170L (no)	2007-06-22	Kaspaseinhibitorer og anvendelse derav
NO20076197L (no)	2008-02-29	Nye 2-azetidinonderivater anvendbare i behandling av hyperlipidemiske tilstander
TW200728305A (en)	2007-08-01	Spiropiperidine beta-sectetase inhibitors for the treatment of alzheimer's disease
NO20063449L (no)	2006-07-27	Substituerte heterocykler og deres anvendelse
NO20045042L (no)	2004-11-19	7-aryl -3,9-diazabicyklo (3.1.1)non-6-en-derivater og deres anvendelse som renin. inhibitorer ved behandling av hypertensjon, kardiovaskulaere og nyresykdommer
MXPA03011484A (es)	2004-03-18	Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades.
NO20063599L (no)	2006-10-27	Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister
ATE497496T1 (de)	2011-02-15	2,4-pyridimediamon-derivate als hemmer von jak- kinasen zur behandlung von autoimmunerkrankungen
NO20081434L (no)	2008-05-19	5-(fenylisoksazolyletoksy)-triazol-3-yl substituert pyridinsammensetninger for behandling av neurologisk, psykiatrisk eller smerteforstyrrelser
NO20063780L (no)	2006-10-27	Fremgangsmate for fremstilling av 2-aminitiazol-5-aromatisk karboksamid som kinase inhibitorer.
WO2008121861A3 (en)	2008-12-24	Pyrazole and pyrrole compounds useful in treating iron disorders
NO20070557L (no)	2007-01-30	Ftalazinderivater som PARP-inhibitorer
NO20074647L (no)	2007-11-09	3,4 dihydro-1H-isoquinolin-2-karboksylsyre-5-ammopyridin-2-yl estere
WO2008030412A3 (en)	2008-11-20	Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
EA200500304A1 (ru)	2005-10-27	Производные 3-(сульфонамидоэтил)индола, предназначенные для использования в качестве миметиков глюкокортикоидов при лечении воспалительных, аллергических и пролиферативных заболеваний
EA201100311A1 (ru)	2011-10-31	Амидные производные гетероарилов и их применение в качестве активаторов глюкокиназы
SE0303180D0 (sv)	2003-11-26	Novel compounds

Legal Events

Date	Code	Title	Description
2015-06-22	FC2A	Withdrawal, rejection or dismissal of laid open patent application